Page 1 of Clinical Trials for ( TaiGen Biotechnology Co. AND Ltd. ) [SPONSOR-COLLABORATORS], 10 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin Versus Levofloxacin in Treating Adult Patients With Community-Acquired Pneumonia
Last Updated: February 8, 2012
Condition(s): Pneumonia
2
Completed
Clinical Study on Oral Nemonoxacin Malate Capsules
Last Updated: July 13, 2011
Condition(s): Healthy Volunteers
3
Completed
Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers
Last Updated: November 23, 2009
Condition(s): Healthy
4
Completed
Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
Last Updated: February 16, 2012
Condition(s): Community-acquired Pneumonia
5
Completed
A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion
Last Updated: February 16, 2012
Condition(s): Healthy
6
Recruiting
Safety, Pharmacokinetics and Stem Cell Mobilization of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
Last Updated: June 14, 2011
Condition(s): Multiple Myeloma; Non-Hodgkin Lymphoma; Hodgkin Disease
7
Not yet recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease
Last Updated: October 20, 2011
Condition(s): Multiple Myeloma; Non-hodgkin's Lymphoma; Hodgkin's Disease
8
Recruiting
A Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics Profiles of Single and Multiple Ascending Oral Doses of TG-2349, and Followed by a Dose-Ranging Study in Hepatitis C Genotype 1 Infected Patients
Last Updated: January 29, 2012
Condition(s): Healthy
9
Completed
Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia
Last Updated: November 23, 2009
Condition(s): Community-Acquired Pneumonia
10
Completed
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
Last Updated: October 12, 2011
Condition(s): Diabetic Foot Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=TaiGen+Biotechnology+Co.%2C+Ltd.

Page 1 of Clinical Trials for ( TaiGen Biotechnology Co. AND Ltd. ) [SPONSOR-COLLABORATORS], 10 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About